Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |